These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
170 related items for PubMed ID: 38351402
1. An Observational Study to Determine the Real-Life Effectiveness of MP-AzeFlu® in Austrian Patients with Persistent Allergic Rhinitis. Marth K, Renner A, Langmayr G, Pohl W, Nguyen DT, Kuhl HC. Drugs Real World Outcomes; 2024 Jun; 11(2):231-240. PubMed ID: 38351402 [Abstract] [Full Text] [Related]
3. Multicentre, non-interventional study to assess the profile of patients with uncontrolled rhinitis prescribed a novel formulation of azelastine hydrochloride and fluticasone propionate in a single spray in routine clinical practice in the UK. Scadding G, Price D, El-Shanawany T, Ahmed S, Ray J, Sargur R, Kumar N. BMJ Open; 2017 Apr 24; 7(4):e014777. PubMed ID: 28442578 [No Abstract] [Full Text] [Related]
4. Real-Life Effectiveness of MP-AzeFlu (Dymista®) in Swedish Patients with Persistent Allergic Rhinitis, Assessed by the Visual Analogue Scale. Stjärne P, Nguyen DT, Kuhl HC. Pragmat Obs Res; 2023 Apr 24; 14():1-11. PubMed ID: 36628265 [Abstract] [Full Text] [Related]
5. MP-AzeFlu provides rapid and effective allergic rhinitis control: results of a non-interventional study in Denmark. Haahr PA, Jacobsen C, Christensen ME. Int Forum Allergy Rhinol; 2019 Apr 24; 9(4):388-395. PubMed ID: 30659752 [Abstract] [Full Text] [Related]
6. A multicenter, prospective, noninterventional study in a Norwegian cohort of patients with moderate-to-severe allergic rhinitis treated with MP-AzeFlu. Dollner R, Lorentz Larsen P, Dheyauldeen S, Steinsvåg S. Allergy Rhinol (Providence); 2017 Oct 01; 8(3):148-156. PubMed ID: 29070272 [Abstract] [Full Text] [Related]
7. The Use of Azelastine Hydrochloride/Fluticasone Propionate in the Management of Allergic Rhinitis in Asia: A Review. Tantilipikorn P, Kirtsreesakul V, Bunnag C, Vangveeravong M, Thanaviratananich S, Chusakul S. J Asthma Allergy; 2024 Oct 01; 17():667-679. PubMed ID: 39045291 [Abstract] [Full Text] [Related]
11. Effect of Specific Immunoglobulin E Response and Comorbidities on Effectiveness of MP-AzeFlu in a Real-Life Study. Klimek L, Price D, Gálffy G, Emmeluth M, Koltun A, Kopietz F, Nguyen DT, van Weissenbruch R, Pohl W, Kuhl HC, Scadding G, Mullol J. Int Arch Allergy Immunol; 2020 Oct 01; 181(10):754-764. PubMed ID: 32829329 [Abstract] [Full Text] [Related]
12. Intranasal spray medications for maintenance therapy of allergic rhinitis. Berger WE, Meltzer EO. Am J Rhinol Allergy; 2015 Oct 01; 29(4):273-82. PubMed ID: 26132312 [Abstract] [Full Text] [Related]
13. MP-AzeFlu in Moderate-to-Severe Allergic Rhinitis: A Literature Review. Klimek L, Berger WE, Bousquet J, Keith PK, Smith P, Sole D, Scadding G, Kuhl HC, Nguyen DT, Kopietz F, Koltun A. Int Arch Allergy Immunol; 2021 Oct 01; 182(11):1026-1035. PubMed ID: 34082425 [Abstract] [Full Text] [Related]
14. Effectiveness of allergic rhinitis treatments in real-life with a focus on MP-AzeFlu. Klimek L, Demoly P, Price D. Expert Rev Clin Pharmacol; 2016 Oct 01; 9(5):705-14. PubMed ID: 26839083 [Abstract] [Full Text] [Related]
15. MP-AzeFlu provides rapid and effective allergic rhinitis control: results of a non-interventional study in Romania. Agache I, Doros IC, Leru PM, Bucur I, Poenaru M, Sarafoleanu C. Rhinology; 2018 Mar 01; 56(1):33-41. PubMed ID: 28942457 [Abstract] [Full Text] [Related]